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OBJECTIVE — Our aim was to characterize familial risks for type 2 diabetes by the type and
number of affected family members, including half-siblings, adoptees, and spouses, to quantify
risks and estimate the contribution of environmental effect.
RESEARCH DESIGN AND METHODS — Families were identiﬁed from the Multigen-
erationRegister,andtype2diabeticpatientswereobtainedfromtheHospitalDischargeRegister.
Standardized incidence ratios were calculated for offspring with type 2 diabetes whose family
members were hospitalized for type 2 diabetes at ages 39 years compared with those lacking
affected family members.
RESULTS — The number of hospitalized type 2 diabetic patients was 157,549. Among
27,895offspring,27.9%hadaparentorsiblingalsohospitalizedfortype2diabetes.Thefamilial
relative risk (RR) ranged from 2.0 to 30, depending on the number and type of probands. The
highestRRsoftype2diabeteswerefoundinindividualswhohadatleasttwosiblingsaffectedby
type 2 diabetes, irrespective of the parental disease. Adoptees showed no risk from adopted
parents.
CONCLUSIONS — The study, the largest yet published, showed that familial RRs varied by
the number and type of affected family member. However, much of the familial clustering
remains yet to be genetically explained. The high risk should be recognized in clinical genetic
counseling. The data from adoptees conﬁrmed the genetic basis of the familial associations, but
those from half siblings and spouses suggested that a smaller part of familial clustering may be
accounted for by environmental factors.
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T
ype 2 diabetes is characterized by
impaired pancreatic -cell function
and insulin action. The prevalence
of type 2 diabetes varies in populations,
and the rate in Sweden has been ranging
from 2 to 4%, with a tendency to increase
(1,2). The disease is thought to be caused
by environmental and inherited factors in
about equal proportions (3). Many envi-
ronmental risks factors are known, and
they include obesity, sedentary lifestyle,
small or large birth weight, stress, nutri-
tional factors, and toxins (1,4). Family
historyisanimportantriskfactorthathas
been shown in twins and singleton sib-
lings (1,3,5–7). The sibling relative risk
(RR) is 3, but it may depend on the age
of onset and probably on the background
incidence of the disease (7–10). Some 20
genes/loci have been associated with type
2 diabetes, some of which are related to
pancreatic-celldysfunction,obesity,in-
sulin sensitivity, or an as yet unknown
function (3,7). However, the observed
RRs are very low, typically ranging be-
tween 1.1 and 1.3, and thus they explain
little for the observed familial clustering
(9,11). Type 2 diabetes is also manifested
in rare Mendelian forms, which account
for 2–5% of all cases and which are
caused by a number of genes (3). Most of
theMendelianformsoftype2diabetesare
of early onset, and they would not be in-
cluded in the present study population
hospitalized at age 39 years for type 2
diabetes. However, latent autoimmune
diabetes of the adult (LADA) could be di-
agnosedinsome10%ofthepatients(12).
LADAshowsfamilialclusteringbothwith
type 2 diabetes and type 1 diabetes; the
familialRRofLADAisclosetothatoftype
2 diabetes (13).
The speciﬁc aims of the present study
were to characterize familial RRs of type 2
diabetes by the type and number of af-
fected family members, because families
with multiple affected individuals were
available in this nationwide study on
157,549 patients. A sufﬁcient number of
half-siblings were also identiﬁed, which
enabled estimation of familial RRs for
them and comparison with full siblings.
In addition, the RR of type 2 diabetes was
analyzed in adoptees by a comparison
withtheirbiologicalandadoptedparents.
The study was conducted by identifying
families from the Multigeneration Regis-
ter, which was linked to the Hospital Dis-
charge Register. The study is unique in
being able to characterize familial RRs in
many types of multiplex families, among
spouses, half-siblings, and adoptees.
Moreover, this is the largest family study
published on type 2 diabetes with the ad-
vantage that all of the results emanate
from a single population of patients with
medicallydiagnoseddiabetesinacountry
of high medical standards and an afford-
able health care system.
RESEARCH DESIGN AND
METHODS— The research database
used for this study is a subset of the na-
tionalMigMed2datasetsattheCenterfor
Primary Health Care Research, Malmo ¨,
Lund University. The MigMed database
was compiled using data from several na-
tionwide Swedish registers provided by
Statistics Sweden, including the Multi-
generation Register in which persons
(second generation) born in Sweden in
1932 and thereafter are registered shortly
after birth and are linked to their parents
(ﬁrst generation). Sibships could be de-
ﬁned for the second generation. National
Census Data (1960–1990) and the Swed-
ish population register (1990–2001)
were incorporated into the database to
obtain information on individuals’ socio-
economic status. Dates of hospitalization
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Swedish Hospital Discharge Register for
years 1964–2007; this Register was
started in 1964, and it reached nation-
widecoveragein1987.Patientsregistered
for hospitalization stayed at least 1 night
in the hospital, usually in wards with spe-
cialists; the Register does not include out-
patients in hospitals or health care
centers. Diagnoses were reported accord-
ing to the different versions of the ICD.
The codes for type 2 diabetes and type 1
diabetes were ﬁrst separated in ICD-10
(1997 onward), and we thus only in-
cluded patients aged 39 years at hospi-
talization;thisagelimitisthesameasthat
used by the National Swedish Diabetes
Registry (14). All linkages were per-
formed using the national 10-digit civic
identiﬁcation number that is assigned to
each person in Sweden for his or her life-
time. This number was replaced by a se-
rial number for each person to provide
anonymity and to check that each indi-
vidual was only entered once, for his or
her ﬁrst hospitalization for type 2 diabe-
tes. More than 11.8 million individuals in
3.5 million families were included in
this database; 8.9 million individuals be-
longedtothesecondgeneration,whohad
reached age 75 years at the end of the
follow-up, which spanned from 1972 to
2007 (15). The population was not static
over the 44 years of follow-up: in year
1972 the second generation, reaching age
40 years was made up of 15,542 men
and 15,749 women compared with
1,841,858menand1,764,906womenby
year 2007. Parental diagnoses were cov-
ered from 1964.
Person-years were calculated from
start of follow-up on 1 January 1972 (i.e.,
when the second generation reached age
40),untilhospitalizationfortype2diabe-
tes, death, emigration, or closing date, 31
December 2007. Standardized incidence
ratios(SIRs)werecalculatedastheratioof
observed to expected number of cases.
The expected number of cases was calcu-
lated for age (5-year groups), sex, period
(5-year groups), region, and socioeco-
nomic status-speciﬁc standard incidence
ratesderivedfromoffspringlackinganaf-
fected family member; person-years at
risk for the familial population are shown
in the tables. For each type of familial
analysis a speciﬁc reference population
wasused.FamilialRRswerecalculatedfor
type 2 diabetes in men and women with
parents, singleton siblings, half-siblings,
adoptees, and spouses, compared with
menandwomenwhoserelativeswerenot
affected by type 2 diabetes, using the co-
hort method as described (16). In this
methodallsiblingsinfamilieswithtwoor
more affected sibling contribute cases,
and they are compared with single case
families using the described person-year
calculation. In families in which more
than two siblings were affected, each was
counted as an individual patient. CIs
(95% CI) were calculated assuming a
Poisson distribution, and they were ad-
justed for dependence between the sib-
ling pairs (16). For the estimation of
interactions for parental probands, the
additive model considered data as 2 
SIR  1.0; the multiplicative model was
ﬁttedasSIRSIR(17);SIRisthefamilial
RR in offspring when one parent was af-
fected. We note that the results are only
approximations because SIRs cannot be
formally compared when different refer-
ence populations were used. Yet, the use
of SIR as an effect measure is useful be-
cause the indirect standardization is efﬁ-
cient in dealing with small numbers of
cases.
RESULTS— The number of type 2 di-
abetic patients aged 39 years at hospi-
talization was 157,549 of whom 27,895
(18,377 men and 9,518 women) be-
longedtotheoffspringgenerationof76
years of age; the parental generation in-
cluded 129,654 individuals. Sex-speciﬁc
familial RRs for type 2 diabetes in single-
ton siblings and in offspring of affected
parentsareshowninTable1.Thefamilial
populations, offspring with affected sib-
lings or with affected parents, accumu-
lated 865,475 and 4,751,609 person-
years at risk, respectively; the average
follow-up time was 14.8 years. The re-
sults showed that daughters of affected
women and female siblings were at some-
what higher risk than any other types of
offspring; however, none of the sex-
speciﬁcresultsweresigniﬁcantlydifferent
from each other. We have also analyzed
the effect of age at diagnosis on familial
RRs. The results showed a modest age de-
pendence; for example, for siblings in
age-band 40–49 years the SIR was 2.95
compared with 2.48 in age-band 60–75
years (data not shown).
Familial RRs are shown in Table 2 by
the type and number of probands in mu-
tually inclusive groups. Also shown are
the number of each type of affected fami-
lies, median age of affected offspring in
thesefamilies,andperson-yearsatriskfor
the familial populations. The number of
affected offspring was 5,662 when a par-
ent was also affected, and 181 had both
parents affected; thus, 20.3% of all off-
spring had a parental family history and
0.7%hadbilinealhistory.Atotalof2,116
siblings were affected, representing 7.6%
of all offspring. The total familial propor-
tion was 27.9% of all offspring. When a
parent was a proband, the RR was 2.03,
but it increased to 2.39 when the parental
age was limited to 75 years, equal to the
maximal age in the offspring generation.
The RR for a singleton sibling of a sibling
proband was somewhat higher at 2.77.
The RRs increased markedly when the
Table 1—Sex-speciﬁc familial RRs for type 2 diabetes according to probands
Proband
Men Women All
O SIR (95% CI) O SIR (95% CI) Person-years O SIR (95% CI)
Singleton siblings
Men 698 2.68 (1.76–4.09) 372 2.63 (1.67–4.12) 572,318 1,070 2.66 (1.77–4.00)
Women 335 2.83 (1.79–4.46) 278 3.20 (2.00–5.09) 293,157 613 2.99 (1.95–4.57)
All 1,033 2.73 (1.81–4.10) 650 2.85 (1.86–4.35) 865,475 1,683 2.77 (1.87–4.11)
Parents
Father 1,586 1.96 (1.86–2.06) 905 1.99 (1.86–2.13) 2,045,048 2,491 1.97 (1.89–2.05)
Mother 2,314 2.01 (1.93–2.10) 1,423 2.17 (2.06–2.28) 2,706,561 3,737 2.07 (2.00–2.14)
All 3,900 1.99 (1.93–2.05) 2,328 2.10 (2.01–2.18) 4,751,609 6,228 2.03 (1.98–2.08)
O, observed number of cases.
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The SIR was 36.86 when two singleton
siblings were probands, and it was 4.59
when a sibling and a parent were pro-
bands.TheSIRwasalsohigh:34.34when
two or more siblings and a parent were
probands. For SIRs 30, half or more
than half of siblings were affected: row 5,
90 affected and 72 unaffected; row 6, 12
affected and 15 unaffected; and row 9, 29
affected and 25 unaffected. Female SIRs
were higher than male SIRs in families of
many affected siblings (e.g., rows 5 and
6), but because of a small number of
cases, the 95% CIs overlapped. The me-
dian age of onset, ranging from 47 to 53
years, showed no large differences be-
tween the family types. The SIR between
spouses was 1.32, which could suggest
that close to one-third of the familial ex-
cess risk of 1.03 (row 1, offspring of an
affected parent SIR 2.03, excess risk
2.03  1.00  1.03) could be explained
by environmental sharing (row 10,
1.32  1.00  0.32). Interactions could
be tested when one or two parents were
affected. Based on row 2 of one affected
parent, an additive effect of 3.78 could be
calculated, compared with a calculated
multiplicative effect of 5.71; according to
row 3 of two affected parents, the true
effects was 5.35, thus close to a multipli-
cative effect.
A total of 77 affected half-siblings
were identiﬁed among a total of 2,777
(1,477maternaland1,300paternal)half-
siblings hospitalized for type 2 diabetes
(Table 3), showing a familial RR of 1.98
and an excess familial risk of 0.98; this
was somewhat more than one-half (55%)
of the excess familial risk for full siblings
(1.77) (Table 3: 2.77  1.00  1.77).
However, only the SIR of 2.28 for mater-
nal half-siblings was signiﬁcant; the ex-
cess risk of 1.28 was 72% of that of full
siblings. The results for adoptees are also
shown among 533 (364 men and 189
women) hospitalized patients. The risk
was 2.16 for adoptees when their biolog-
ical parents were probands, similar to
data in Table 2. However, when the
adopted parents were probands, there
was no excess risk and the SIR was 0.95;
the SIR was 0.79 when the adoptee was
male and it was 1.27 when the adoptee
was female.
CONCLUSIONS — Theuseofhospi-
talized patients offers advantages and dis-
advantages to etiological studies. One
limitation is that all patients are not hos-
pitalized,andthereisprobablyaselection
to severe disease presentation and com-
plications. By extrapolation from regional
rates, it has been estimated that there
would be some 350,000 type 2 diabetic
patients in Sweden in year 2004 (18). On
the other hand, at the same time, the Na-
tional Diabetes Register in Sweden only
included 57,000 patients with the age of
onset of 39 years (12,14). The Register
ﬁgure is an underestimate because only
50% of the primary care centers and 90%
of diabetes clinics have participated.
Thus, the present overall ﬁgure of
157,549patientsaged39yearswhoare
hospitalizedseemstobebetweenTheNa-
tional Diabetes Register number, cor-
rected for full coverage and the
extrapolated ﬁgure for type 2 diabetic pa-
tients. When all patients are not hospital-
ized, selection may take place whereby
family members of hospitalized patients
may preferentially seek hospitalization.
However,suchselectionshouldbelargest
amongcohabitingspousesandthespouse
correlation of 1.32 was well below any of
thefamilialriskestimates.Theuseofhos-
Table 3—Familial RRs for type 2 diabetes in half-siblings and adoptees
Men Women All
O SIR (95% CI) O SIR (95% CI)
Person-
years O SIR (95% CI)
Half-siblings
By mother 30 2.35 (1.12–4.75) 16 2.15 (0.87–4.94) 29,435 46 2.28 (1.18–4.3)
By father 18 1.54 (0.64–3.45) 13 1.84 (0.69–4.47) 32,656 31 1.65 (0.79–3.32)
All 48 1.96 (1.02–3.68) 29 2.00 (0.95–4.07) 62,091 77 1.98 (1.10–3.5)
Adoptees
By biological
parents 45 2.06 (1.50–2.75) 73 2.24 (1.75–2.81) 49,749 118 2.16 (1.79–2.59)
By adopted
parents 20 0.79 (0.48–1.23) 15 1.27 (0.71–2.1) 50,260 35 0.95 (0.66–1.32)
O, observed number of cases.
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such as access to a nationwide patient
pool and reasonably high diagnostic ac-
curacy because the discharge diagnoses
are often delivered by specialists during
extended examinations in the clinic. In
Sweden, hospitalization for type 2 diabe-
tes may be a secondary or tertiary referral
step; type 2 diabetes is diagnosed in pri-
mary care centers, which refer the pa-
tients to hospital outpatient clinics or
directly to inpatient clinics. Hospital clin-
ics are directed by specialists in internal
medicine or endocrinology/diabetology
(14). With poor diagnostic accuracy, any
effects would be expected to regress to-
ward null, which appeared not to be the
case with the present results.
In the present offspring population,
with a maximal age of 75 years, 27.9%
hadanaffectedparentorsiblingand0.7%
had two affected parents. These results
can be compared with those of the Fra-
minghamoffspringstudyinwhich23.7%
of the offspring had an affected parent (in
our study 20.3%) and 1.7% had two af-
fected parents (19).
The observed familial RR of 2.03 in
offspring of affected parents increased to
2.39 when parental age was limited to the
maximal offspring age of 75 years. This
RR was close to the risk of 2.77 for single-
tonsiblings,leavinglittlespaceoverallfor
recessiveorchildhoodsharedeffects.The
results for the familial risk were in line
with those in the literature (6,10,19,20).
The RR from two affected parents was
5.35, which was closer to the modeled
multiplicative (5.71) than to the additive
(3.78) estimate. In the Framingham and
PimaIndianstudies,thebilinealestimates
have been close to the additive models
(19).Thegeneralinterpretationofthead-
ditive effect is that the underlying genes
are noninteractive and inﬂuence different
pathways (19,21). However, none of the
models used considered the possible en-
vironmental contribution to the risk esti-
mates, discussed later.
Sex-speciﬁc analysis in singleton sib-
lings and in offspring of affected parents
showed modest female excesses: daugh-
ters of affected women were at somewhat
higher risk than any other types of off-
spring, similar to female siblings. Sex-
speciﬁc differences were largest for
sibships of multiple affected patents.
However, none of the sex-speciﬁc results
were signiﬁcantly different from each
other. The literature on sex effect is con-
troversial, and the present data agree that
the differences are not large (10,19).
With the present large sample size,
we were able to deﬁne families with mul-
tipleaffectedindividualsandhighfamilial
risks. When two or more singleton sib-
lings were probands, the familial RR ex-
ceeded 30, irrespective of the affected
parents. This level of risk was probably as
high as was possible for a relatively com-
mon disease and in fact one-half or more
of all siblings were affected in these fami-
lies. These high-risk families accounted
for 0.4% of all offspring, and they are
likely to include late onset Mendelian
forms of type 2 diabetes. Notably, 102 of
131 patients from the high-risk families
(SIR 30) lacked affected parents, which
would suggest recessive inheritance. The
known monogenic forms of type 2 diabe-
tes include maturity-onset diabetes of
the young (MODY) and other very rare
syndromes (22). The six genetically char-
acterized MODY subtypes cause hyper-
glycemia before age 25 years, but
unknown MODY loci may represent 20–
50% of the cases and some of the identi-
ﬁed high-risk families may carry these
MODY-X loci (22). However, some of the
families may even belong to the known
MODYtypes,buttheﬁrsthospitalizations
of the family members took place before
the Hospital Discharge Register was na-
tionwide in year 1987. Considering that a
familialriskof10canbeconveyedbyrare
dominant or additive genes of high risk
(allelefrequencyof1%,oddsratio100)
or more common recessive genes of very
highrisk(allelefrequencyof20%,odds
ratio 200) (11), none of the recently de-
tectedlow-penetrancegenesalonebelong
to this domain of genes. However, the
combinations of risk variants in rare indi-
viduals would mimic the effects of rare
high-risk alleles (3). The effects would be
strong if the variants interacted with each
other, which, however, may not be the
case with the type 2 diabetes genes de-
tected. Accordingly, the addition of gene
tests into the available clinical parameters
causes a negligible improvement in pre-
diction (23,24). Such results have been a
disappointmentforotherdiseasesaswell,
however, not unexpectedly (25). In con-
trast, the present results of familial risk of
30 when two siblings have diabetes
have clinical relevance. Even the risk of 5
fromtwoaffectedparentsorfromaparent
and sibling is of concern.
Many environmental and host factors
predispose to type 2 diabetes, but the low
spouse correlation of 1.32 suggests that
these factors had a limited, yet deﬁnite,
inﬂuence on the observed familial aggre-
gation.Suchaneffectwasnotseenamong
adoptees, who showed no excess through
adopted parents, but the case numbers
were limited. The risk for adoptees from
biological parents was as high as that for
offspring of affected parents in the whole
population.Thedataonhalf-siblingssup-
ported the contribution of environmental
factors to the familial aggregation; the
risks were higher for maternal than for
paternal half-siblings, which may be ex-
plained by the fact that, after parental di-
vorce, the children have usually lived
withtheirmotherinSweden.Thefamilial
excess risk for maternal half-siblings was
72%ofthatforfullsiblings;theexpectation
from additive genetic effects is 50%. How-
ever, this ﬁgure is only an approximation
becausecomparisonoftwoSIRsmaynotbe
accurate. With such reservations, these
data, together with the spouse correlation,
suggestthatclosetoone-thirdofthefamilial
risk for type 2 diabetes may have an envi-
ronmental origin in families of two affected
individuals; in multiplex families, this pro-
portion is likely to be less.
In summary, the present family study
on type 2 diabetes, the largest one yet
published, showed that in the offspring
population hospitalized for type 2 diabe-
tes between ages 40 and 75 years, 27.9%
have a parent or sibling also hospitalized
for type 2 diabetes. The familial risk
ranged from 2 to 30, depending on the
number and type of probands. Probably
much of the familial clustering remains
yet to be genetically explained. The high
risk should be recognized in clinical ge-
netic counseling. The data from adoptees
conﬁrmed the genetic basis of the familial
associations, whereas the data from half-
siblings and spouses suggested that close
to one-third of familial clustering may be
accountedforbyenvironmentalfactorsin
families of two affected individuals.
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